Integra LifeSciences cuts 2026 guidance after flooding impact

Princeton, New Jersey - Integra LifeSciences has reduced its 2026 earnings forecast due to flooding-related disruptions at its Cincinnati manufacturing plant. The company now anticipates third-quarter revenue of $410 million to $412 million and adjusted earnings per share of $0.55 to $0.59 for Q3. For the entire year, Integra has lowered its revenue outlook to $1.634 billion to $1.654 billion and adjusted earnings per share to $2.30 to $2.40.

The flooding damaged portions of the facility, equipment, inventory, and other assets, causing a $7 million revenue shortfall in Q3 and an estimated $15 million to $20 million hit in Q4. Integra expects to resume full operations at the site in the second quarter of 2027. The company has used its inventory and alternative supply sources to mitigate the impact.

Chairman and CEO Stuart Essig expects operating cash flow to exceed $85 million in Q3 and $190 million to $200 million for the year. Full third-quarter 2026 results will be disclosed in a conference call in October 2026.